amodiaquine has been researched along with Disease Exacerbation in 1 studies
Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.
amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akano, K | 1 |
Fatunmbi, B | 1 |
Ntadom, G | 1 |
Ayede, AI | 1 |
Aderoyeje, T | 1 |
Bakre, A | 1 |
Alebiosu, OT | 1 |
Akpoborie, O | 1 |
Okafor, C | 1 |
Gbotosho, GO | 1 |
Folarin, OA | 1 |
Ebenebe, JC | 1 |
Ambe, J | 1 |
Wammanda, R | 1 |
Jiya, N | 1 |
Finomo, F | 1 |
Emechebe, G | 1 |
Mokuolu, O | 1 |
Agomo, C | 1 |
Oguche, S | 1 |
Happi, C | 1 |
Sowunmi, A | 1 |
1 other study available for amodiaquine and Disease Exacerbation
Article | Year |
---|---|
Clinical illness and outcomes in Nigerian children with persistent early-appearing anaemia following initiation of artemisinin-based combination treatments of uncomplicated falciparum malaria.
Topics: Amodiaquine; Anemia; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, | 2019 |